Loss of FOXO3 was associated with altered metabolism and function of astrocytes, increased β-amyloid plaques, a pathological hallmark of Alzheimer’s disease, and synapse loss. This evidence concerns the gene FOXO3 and early-onset autosomal dominant Alzheimer disease.